Capricor Therapeutics Inc (NAS:CAPR)
$ 4.81 -0.02 (-0.41%) Market Cap: 153.82 Mil Enterprise Value: 115.92 Mil PE Ratio: 0 PB Ratio: 8.25 GF Score: 70/100

Capricor Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

May 25, 2022 / 01:30PM GMT
Release Date Price: $3.38 (-0.88%)
Trevor Levy
H.C.Wainwright & Co., LLC - Analyst

Good afternoon, everyone, and thank you for tuning in today to H.C. Wainwright 2022 Global Investment Hybrid Conference. My name is Trevor Levy, and I am on the corporate access team at H.C. Wainwright. And now I'm pleased to welcome our presenter, AJ Bergmann, the Chief Financial Officer of Capricor Therapeutics.

AJ Bergmann
Capricor Therapeutics, Inc. - CFO

Thanks, Trevor, and thanks to Wainwright for hosting. I'm not in attendance, obviously, in Miami, I wish I was. I'm in partly cloudy San Diego. Again, my name is AJ Bergmann. I'm the Chief Financial Officer at Capricor Therapeutics. I have been with the company approximately 10 years. Capricor is a small San Diego-based biotechnology company. Our ticker symbol is CAPR, and we are listed on the NASDAQ.

Let me give a overview of pretty much everything on this slide, but just to bring fully up to [seed] on where we are as a company. Whether this is the many presentation you've heard of Capricor or one of your first, we are focused on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot